Crushed Earnings, Raised Guidance—This Might Be the Start of a Retail Revival

Wall Street just got a jolt from retail. Strong results and raised guidance sent this stock soaring 38%, fueling speculation that this could be the early spark of a broader sector recovery.

Forget rate cuts. Forget AI. Forget the trade war.

The real money is moving into:

→ Utility – Powers 1 in 5 U.S. homes, trading under $20
→ Staples – 18 recession-proof brands, consistent dividend growth
→ Healthcare – Telehealth disruptor up 300% since 2021

These aren’t just safe havens—they’re growth rockets in disguise.

Get my free report, “3 Defensive Stocks to Buy Now“ with:

Free for a limited time before it’s paywalled.

[Download Your Copy]

Wall Street closed higher on Thursday as weaker private payrolls data signaled a cooling labor market, boosting expectations for a Federal Reserve rate cut this month.

Dollar Tree (NASDAQ: DLTR) slid after its Q2 report, but the drop looks more like bargain-bin pricing than a broken story.

Guidance disappointed on earnings, yet revenue trends and store expansion kept the longer-term outlook intact.

The split from Family Dollar is starting to show results. Sales from continuing operations rose by double digits, outpacing many retail peers.

Cash Flow as Currency

Dollar Tree doesn’t cut dividend checks, but it does aggressively buy back stock. Share count dropped in Q2, and a fresh re-authorization means that pace isn’t slowing down.

Capital return through buybacks signals confidence. With balance sheet leverage low, financial flexibility is firmly intact.

Stores That Sell Themselves

Same-store sales climbed more than 6%, with higher traffic and bigger basket sizes doing the heavy lifting. New openings and 3.0 remodels added even more fuel.

Margins tightened a bit but stayed healthy. Operating income still cleared estimates, proving efficiency is holding up in the face of tariffs.

Cash Registers Still Ringing

Dollar Tree’s dip may be short-lived if analysts are right. Forecasts point toward potential highs near $130, a solid rebound from current levels.

Institutional investors agree, with ownership near 98% and steady buying across 2025. Support like that suggests this discount chain may be a premium opportunity.

General Motors (NYSE: GM) is cutting EV production at its Tennessee and Kansas City plants.

Cadillac Lyriq, Vistiq, and Chevy Bolt models will see slower rollouts as demand slips without federal subsidies.

Rather than chasing volume, GM is hitting pause to better match supply with reality. Pulling back now helps avoid a pile-up of unsold cars later.

Cash Before Cars

EV programs are pricey, and without government credits, margins get thin fast. By cutting output, GM keeps profitability from taking a direct hit.

Investors tend to reward discipline over bravado. Protecting cash flow shows GM is steering for resilience, not racing for headlines.

Old Engines, New Cushion

Unlike pure-play EV makers, GM can still lean on its combustion lineup. Trucks and SUVs deliver steady income while EV growth takes its time.

That safety net matters in a volatile market. Diversification buys GM breathing room to pace its electric rollout.

What Shareholders Really Want

Scaling back today conserves resources for when demand recovers. To investors, that reads as prudence, not retreat.

It also leaves space to protect dividends and long-term returns. For patient holders, GM’s measured pace may prove more rewarding than flashy expansion.

Most portfolios deliver “average.”

But if you’re reading this, you’re not after average.

That’s why our team just unveiled 5 carefully selected stocks with the potential to deliver massive upside.

What sets them apart?

Past reports from this series have highlighted stocks that posted gains of +175%, +498%, and even +673%.¹

Now, it’s your chance to see the latest 5 picks—completely free.

[Click here to claim your copy before midnight tonight]

Extraordinary opportunities don’t come often. Don’t miss this one.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Texas Instruments (NASDAQ: TXN) told investors that the demand boost from tariffs has already faded.

Customers rushed to stock up earlier this year, leaving the back half of 2025 looking lighter than the first.

The update may sound like a warning, but it’s more of a reality check. Artificial demand spikes rarely last, and TI is adjusting without losing its long-term focus.

Investing While It Hurts

Management isn’t trimming capex just because revenue looks softer.

Billions in new fabs and equipment are still on the docket, a reminder that TI is building for decades, not quarters.

That spending does pinch free cash flow, and buybacks are being paced more slowly.

But dividends remain comfortably backed by the company’s bread-and-butter analog chips, which churn out steady margins even when the cycle cools.

Playing a Cleaner Hand

TI made it clear that no government equity stake applies, which means no dilution and no loss of control.

That independence is a selling point for investors. The story is simpler: capital discipline, shareholder-friendly policies, and fewer policy headaches.

The Upshot

Texas Instruments isn’t immune to demand swings, but it’s proving it can steer through them without panic.

Heavy investment now sets up stronger returns later, and dividends keep the story attractive in the meantime.

For investors, that balance of grit and predictability is what makes TI worth a look, even in a slower cycle.

👉 Click here to get our closing report to your cell for free!

American Eagle Outfitters [AEO] $18.80 (+38.03%)

American Eagle soared after crushing earnings expectations and reinstating strong full-year guidance, signaling renewed momentum ahead of the back-to-school season.

Virnetx Holding Corp [VHC] $19.50 (+30.62%)

VirnetX popped after earning critical DoD certifications, opening the door to high-security U.S. defense contracts and military partnerships.

Nektar Therapeutics [NKTR] $35.93 (+25.85%)

Nektar climbed after a rival’s trial underwhelmed, boosting hopes that its own atopic dermatitis drug could seize market advantage.

Neonode Inc [NEON] $6.16 (-71.38%)

Neonode plunged after the Samsung patent lawsuit settlement yielded just $15–20M, far below investor hopes for a billion-dollar windfall.

Artelo Biosciences Inc [ARTL] $4.35 (-50.34%)

Artelo dropped after pricing a discounted $3M public offering, raising concerns about dilution and near-term funding needs.

Endava Plc [DAVA] $9.97 (-30.67%)

Endava sank after weak guidance and falling revenue overshadowed a narrow EPS beat, reigniting fears about stalled enterprise IT demand.

Analysts are split on whether President Trump’s trade policies will spark a market meltdown or fuel long‑term strength.

Wall Street’s caught in a tug‑of‑war, driving volatility to new highs. 

The IMF warns that rising tariffs will boost inflation without causing a recession, keeping investors on edge.

When the tariff pause sent stocks surging, savvy options traders banked big, proof that chaos can equal opportunity.

Get this FREE e‑book, Mastering Options Trading - A Beginner’s Guide to Success, and learn how to trade any market:

Don’t let unpredictable swings catch you off guard.

Download your free guide now before this offer expires!

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.